Earnings History Data for Vaccinex, Inc. (VCNX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Vaccinex, Inc.

Vaccinex, Inc. is a clinical-stage immunotherapy company. It engages in the discovery and development of biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases and autoimmune disorders. The company's product pipeline consists of VX15, VX5 and VX25 which are in clinical stage. Vaccinex, Inc. is based in Rochester, New York.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
17-05-2021 PM VCNX Vaccinex, Inc. 57.00 -0.26 -0.39 0.00 Vaccinex reports Q1 results
[5/17/2021 8:30 AM]
2.16 0.05 
(2.37%)
2.20 0.09 
(4.27%)
1.63 - 9.56 327,376 250,000 647
16-03-2021 PM 8:05 AM ET
(Mar 16)
VCNX Vaccinex, Inc. 74.10 N/A -0.33 -0.38 Vaccinex beats on revenue
[3/16/2021 9:21 AM]
3.64 0.08 
(2.39%)
3.79 0.23 
(6.46%)
1.63 - 9.56 3,401,891 1,112,788 148,142
13-11-2020 PM VCNX Vaccinex, Inc. 44.00 -0.44 -0.53 0.00 Vaccinex EPS misses by $0.01
[11/13/2020 8:35 AM]
1.97 -0.01 
(-0.50%)
0.0 0.0 
(0.00%)
1.63 - 12.23 609,721 1,645,026 0